Upstream Bio, Inc. (UPB) - Total pendapatan perusahaan
Upstream Bio Inc (UPB) relies on outsourcing antibody production while maintaining sufficient capital to complete drug trials. On the GURU.Markets platform, the company's sales volume dynamics demonstrate market positions where the value of 0.00 characterizes this level. However, geopolitical tensions and logistics disruptions create risks for conducting international tests, which could lead to financial losses.
Rincian analitis perusahaan Upstream Bio (UPB)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Upstream Bio Inc|UPB - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Upstream Bio, Inc.|UPB - Utang perusahaan|Rasio utang marang aset resik Upstream Bio Inc|UPB - Utang jangka dawa perusahaan|Utang jangka cendhak Upstream Bio|Rasio cepet upstreambio.com
- data bathi resik lan rasio valuasi:
UPB - Bathi resik perusahaan|Bathi mangsa ngarep Upstream Bio Inc|UPB - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi upstreambio.com|UPB - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Upstream Bio Inc|UPB - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Upstream Bio|UPB - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan upstreambio.com|UPB - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Upstream Bio Inc
- indikator volume dodolan lan pendapatan:
Analisis komprehensif perusahaan:Upstream Pharma - UPB
Investors must find a balance between operational risks and the future return on invested capital. Upstream Bio Inc (UPB) is currently focusing on R&D antibody development, utilizing IPO proceeds to cover expenses. An analysis of the company's monthly sales converts gross revenue into a continuous curve, reflecting the product realization rate. Growth in this indicator signals an expansion of market share. The current absence of revenue confirms a stage of planned reserve consumption.
Pesaing wigati
Volume dodolan perusahaan ARGX (argenx BVBA)|Pendapatan lan volume dodolan BNTX|ABVX - Total pendapatan perusahaan|ADMA Biologics, Inc. - Dodolan perusahaan|Pendapatan lan volume dodolan Protagonist Therapeutics, Inc. PTGX|IMVT - Pendapatan perusahaan|Pendapatan tahunan perusahaan KNSA|Grifols, S.A. (GRFS) - Pendapatan perusahaan|ADPT - Pendapatan reged perusahaan|Dodolan perusahaan CLDX|AUPH (Aurinia Pharmaceuticals Inc) - Total dodolan perusahaan|Pendapatan perusahaan BioCryst Pharmaceuticals Inc (BCRX)|VERA (Vera Corp) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan DNTH (Dianthus Therapeutics)|pharvaris.com (PHVS) - Total pendapatan perusahaan|AbCellera - Pendapatan lan volume dodolan|TRML - Pendapatan lan volume dodolan|Intrexon (PGEN) - Pendapatan perusahaan|Dodolan perusahaan Pharming Corp|Dodolan perusahaan NKTR|ZBIO: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan IMNM|Pendapatan perusahaan GOSS (Gossamer Bio Inc)|Pendapatan lan volume dodolan KALV (KalVista Pharmaceuticals Inc)|Pendapatan reged perusahaan Septerna Pharma (SEPN)|PVLA - Pendapatan perusahaan|Total pendapatan perusahaan savarapharma.com|RIGL (Rigel Pharmaceuticals, Inc.) - Dodolan perusahaan|AnaptysBio Inc - Pendapatan dodolan perusahaan|ATXS (Astria Pharma) - Pendapatan lan volume dodolan|enGene Corp (ENGN) - Pendapatan reged perusahaan|Pendapatan perusahaan RAPT Therapeutics, Inc. (RAPT)|aerovatetx.com - Volume dodolan perusahaan|Pendapatan lan volume dodolan ACRS (Aclaris Therapeutics, Inc.)|KYTX - Dodolan perusahaan|TLSA: Dodolan perusahaan|CABA - Pendapatan lan volume dodolan|Ventyx Biosciences (VTYX) - Pendapatan perusahaan|Pendapatan tahunan perusahaan THTX (theratech.com)|AVTX (Avalo Therapeutics) - Pendapatan lan volume dodolan|Pendapatan perusahaan ELDN|Pendapatan perusahaan Agenus Inc (AGEN)|CLYM: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan ZURA (Zura Bio Limited)|Pendapatan dodolan perusahaan ATYR|Adagene Corp - Pendapatan lan volume dodolan|IMA - Pendapatan lan volume dodolan|shattucklabs.com (STTK) - Pendapatan perusahaan|Equillium - Pendapatan dodolan perusahaan|Pendapatan perusahaan Connect Biopharma Holdings|Dodolan perusahaan Immunic Inc (IMUX)|Pendapatan lan volume dodolan ATRA|Pendapatan lan volume dodolan inflarx.de (IFRX)|X4 Pharma - Dodolan perusahaan|Pendapatan dodolan perusahaan ACET|Celularity Corp - Pendapatan lan volume dodolan|Pendapatan reged perusahaan inmunebio.com INMB|Barinthus Biotherapeutics plc (BRNS) - Pendapatan perusahaan|Dodolan perusahaan Kezar Life Sciences Inc.|Pendapatan perusahaan SAB Biotherapeutics, Inc|Dodolan perusahaan Akari Therapeutics, Plc (AKTX)|Dodolan perusahaan ENLV (Enlivex Therapeutics)|Pendapatan lan volume dodolan q32bio.com (QTTB)|Pendapatan perusahaan GeoVax GOVX|EDSA: Volume dodolan perusahaan|iBio Corp - Pendapatan lan volume dodolan|Total pendapatan perusahaan Carisma Therapeutics|XTLB (XTL Biopharmaceuticals) - Dodolan perusahaan|Bolt Biotherapeutics, Inc. (BOLT) - Pendapatan lan volume dodolan|Pendapatan perusahaan HCW Biologics, Inc.|Aptevo - Pendapatan tahunan perusahaan|Pendapatan perusahaan AIM ImmunoTech (AIM)|Pendapatan reged perusahaan aditxt.com|GRI Bio, Inc. - Dodolan perusahaan|Total dodolan perusahaan XRTX (xortx.com)|HIND - Pendapatan perusahaan|Pendapatan dodolan perusahaan REVB (Revelation Biosciences Inc)|INDP: Pendapatan lan volume dodolan|Total pendapatan perusahaan BiondVax Pharmaceuticals (SCNI)|CALI (CalciMedica Inc) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Affimed Therapeutics|Pendapatan perusahaan Allakos Inc. (ALLK)|Dodolan perusahaan hookipapharma.com HOOK|IGM Biosciences - Dodolan perusahaan|Pendapatan dodolan perusahaan ITOS|Ocean Biomedical, Inc. - Pendapatan lan volume dodolan|TCBP: Pendapatan perusahaan|THRD: Pendapatan lan volume dodolan
